Gemcitabine Gene Set

Dataset	DrugBank Drug Targets
Category	physical interactions
Type	drug
Description	A 2'-deoxycytidine having geminal fluoro substituents in the 2'-position. An inhibitor of ribonucleotide reductase, gemcitabine is used in the treatment of various carcinomas, particularly non-small cell lung cancer, pancreatic cancer, bladder cancer and breast cancer. (Chemical Entities of Biological Interest Ontology, CHEBI_175901)
External Link	http://www.drugbank.ca/drugs/DB00441
Similar Terms
Downloads & Tools

Genes

11 interacting proteins for the Gemcitabine drug from the curated DrugBank Drug Targets dataset.

Symbol	Name
ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1
ABCC10	ATP-binding cassette, sub-family C (CFTR/MRP), member 10
CDA	cytidine deaminase
CMPK1	cytidine monophosphate (UMP-CMP) kinase 1, cytosolic
DCK	deoxycytidine kinase
RRM1	ribonucleotide reductase M1
SLC28A1	solute carrier family 28 (concentrative nucleoside transporter), member 1
SLC28A3	solute carrier family 28 (concentrative nucleoside transporter), member 3
SLC29A1	solute carrier family 29 (equilibrative nucleoside transporter), member 1
SLC29A2	solute carrier family 29 (equilibrative nucleoside transporter), member 2
TYMS	thymidylate synthetase